Seelos Therapeutics, Inc. Common Stock
SEEL
SEEL was delisted on the 15th of October, 2024.
2 hedge funds and large institutions have $4.77K invested in Seelos Therapeutics, Inc. Common Stock in 2024 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 12 closing their positions.
87% less funds holding
Funds holding: 15 → 2 (-13)
97% less capital invested
Capital invested by funds: $145K → $4.77K (-$140K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
AdvisorShares Investments
Bethesda,
Maryland
|
+$6.79K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MWM
Modera Wealth Management
Westwood,
New Jersey
|
-$40.6K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$31.8K |
| 3 |
Morgan Stanley
New York
|
-$2.54K |
| 4 |
BlackRock
New York
|
-$1.33K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$357 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AI
1
AdvisorShares Investments
Bethesda,
Maryland
| $4.77K | +$6.79K | +2,430 | +13% |
|
|
VWWMG
2
Vermillion & White Wealth Management Group
Phoenixville,
Pennsylvania
| $2 | – | – | – |
|
|
MWM
3
Modera Wealth Management
Westwood,
New Jersey
| – | -$40.6K | -10,805 | Closed |
|
|
4
UBS Group
Zurich,
Switzerland
| – | -$31.8K | -8,477 | Closed |
|
|
5
Morgan Stanley
New York
| – | -$2.54K | -675 | Closed |
|
|
6
BlackRock
New York
| – | -$1.33K | -354 | Closed |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| – | -$357 | -95 | Closed |
|
8
Bank of America
Charlotte,
North Carolina
| – | -$120 | -32 | Closed |
|
9
JP Morgan Chase
New York
| – | -$116 | -31 | Closed |
|
10
Group One Trading
Chicago,
Illinois
| – | -$45 | -12 | Closed |
|
|
CA
11
Crewe Advisors
Salt Lake City,
Utah
| – | -$27 | -7 | Closed |
|
|
DB
12
Danske Bank
Copenhagen K,
Denmark
| – | -$8 | -2 | Closed |
|
13
Wells Fargo
San Francisco,
California
| – | -$8 | -2 | Closed |
|
|
NFSG
14
Newbridge Financial Services Group
Boca Raton,
Florida
| – | -$4 | -1 | Closed |
|
SEEL Hedge Fund Activity: Q4 2024 in Review
2 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Seelos Therapeutics, Inc. Common Stock (SEEL) for Q4 2024, worth a combined $4.77K — down 97% from $145K a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of SEEL and 0 opened new positions — a net loss of 12 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was AdvisorShares Investments, adding an estimated $6.79K. The largest seller was Modera Wealth Management, exiting entirely with an estimated $40.6K sold.
- 2 institutional investors held Seelos Therapeutics, Inc. Common Stock (SEEL) as of Q4 2024, down from 15 in Q3 2024.
- Funds reported $4.77K of Seelos Therapeutics, Inc. Common Stock stock for Q4 2024, down 97% quarter-over-quarter.
- 0 funds opened new Seelos Therapeutics, Inc. Common Stock positions in Q4 2024 and 12 closed out, a net change of -12 holders.
- The largest Seelos Therapeutics, Inc. Common Stock buyer in Q4 2024 was AdvisorShares Investments, an estimated $6.79K added.
- The largest Seelos Therapeutics, Inc. Common Stock seller in Q4 2024 was Modera Wealth Management, an estimated $40.6K sold.
Based on aggregated 13F filings for Q4 2024.